Aliases & Classifications for Neuritis

MalaCards integrated aliases for Neuritis:

Name: Neuritis 12 51 41 14 69
Peripheral Neuritis 12

Classifications:



External Ids:

Disease Ontology 12 DOID:1803
MeSH 41 D009443
NCIt 46 C116381
UMLS 69 C0027813

Summaries for Neuritis

MalaCards based summary : Neuritis, also known as peripheral neuritis, is related to optic neuritis and neuromyelitis optica, and has symptoms including sciatica and neuralgia. An important gene associated with Neuritis is PMP2 (Peripheral Myelin Protein 2), and among its related pathways/superpathways are Cytokine Signaling in Immune system and PAK Pathway. The drugs Methylprednisolone and Prednisolone have been mentioned in the context of this disorder. Affiliated tissues include eye, brain and t cells, and related phenotypes are hematopoietic system and behavior/neurological

Wikipedia : 72 Neuritis (/njʊəˈraɪtɪs/) is inflammation of a nerve or the general inflammation of the peripheral... more...

Related Diseases for Neuritis

Diseases related to Neuritis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 430)
# Related Disease Score Top Affiliating Genes
1 optic neuritis 32.8 AQP4 MAG MBP MOG MPZ MT-ND4
2 neuromyelitis optica 32.8 AQP4 MBP MOG
3 transverse myelitis 32.4 AQP4 MBP TNF
4 optic nerve disease 31.5 AQP4 MOG MT-ND4
5 myelitis 30.4 AQP4 MBP MOG TNF
6 acute disseminated encephalomyelitis 30.4 AQP4 MBP MOG
7 miller fisher syndrome 30.0 MAG TNF
8 leprosy 3 29.9 IFNG IL4 TNF
9 aseptic meningitis 29.8 IFNG IL1B TNF
10 q fever 29.8 IFNG IL1B TNF
11 allergic encephalomyelitis 29.8 CXCL10 MBP MOG
12 acquired immunodeficiency syndrome 29.7 IFNG IL1B TNF
13 meningitis 29.7 CCL2 IFNG IL1B TNF
14 internuclear ophthalmoplegia 29.7 AQP4 MBP MOG
15 crohn's disease 29.7 IFNG IL1B TNF
16 chronic inflammatory demyelinating polyradiculoneuropathy 29.6 IFNG MBP MPZ PMP22
17 typhoid fever 29.6 IFNG IL1B TNF
18 chlamydia 29.5 IFNG IL1B TNF
19 laryngitis 29.5 IL1B TNF
20 chikungunya 29.4 CCL5 IL1B TNF
21 rubella 29.4 IL4 MOG TNF
22 arthritis 29.4 CCL2 IFNG IL1B TNF
23 polyneuropathy 29.3 MAG MBP MPZ PMP22
24 charcot-marie-tooth disease 29.3 MBP MPZ PMP2 PMP22
25 mycobacterium tuberculosis 1 29.2 CXCL10 IFNG IL4 TNF
26 poliomyelitis 29.1 IFNG IL4 TNF
27 ulcerative colitis 29.1 IFNG IL1B TNF
28 pulmonary tuberculosis 29.0 IFNG IL4 TNF
29 pneumonia 29.0 CCL2 CCL5 IL1B TNF
30 allergic hypersensitivity disease 28.9 CCL5 IFNG IL4
31 scleritis 28.9 CCL2 IL4 TNF
32 myasthenia gravis 28.9 IFNG IL4 MBP TNF
33 uveitis 28.8 CCL2 CXCL10 IFNG IL4 TNF
34 polyradiculoneuropathy 28.7 CCL5 IFNG MBP MPZ PMP2 PMP22
35 toxoplasmosis 28.7 IFNG IL1B IL4 TNF
36 endometriosis 28.7 CCL2 CCL5 IL1B
37 colitis 28.7 IFNG IL1B IL4 TNF
38 encephalitis 28.6 AQP4 CCL2 CCL5 CXCL10 IL1B MOG
39 rheumatoid arthritis 27.8 CCL2 CCL5 IFNG IL1B IL4 TNF
40 systemic lupus erythematosus 27.7 CCL2 CCL5 CXCL10 IFNG IL1B IL4
41 relapsing-remitting multiple sclerosis 27.4 AQP4 CCL2 CCL5 IFNG IL4 MBP
42 malaria 27.1 CCL2 CCL5 CXCL10 IFNG IL1B IL4
43 psoriasis 26.9 CCL2 CCL5 CXCL10 IFNG IL1B IL4
44 demyelinating disease 26.9 AQP4 CCL2 CCL5 CXCL10 IFNG IL1B
45 multiple sclerosis 26.8 AQP4 CCL2 CCL5 CXCL10 IFNG IL1B
46 acute retrobulbar neuritis 12.2
47 brachial plexus neuritis 12.1
48 isolated optic neuritis 12.0
49 amyotrophy, hereditary neuralgic 11.7
50 chronic relapsing inflammatory optic neuropathy 11.6

Graphical network of the top 20 diseases related to Neuritis:



Diseases related to Neuritis

Symptoms & Phenotypes for Neuritis

UMLS symptoms related to Neuritis:


sciatica, neuralgia

MGI Mouse Phenotypes related to Neuritis:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10 MAG MBP AQP4 MOG CCL5 CXCL10
2 behavior/neurological MP:0005386 9.97 MAG MBP AQP4 MOG MPZ PMP2
3 immune system MP:0005387 9.93 MBP AQP4 MOG CCL2 CCL5 CXCL10
4 nervous system MP:0003631 9.73 MBP AQP4 MOG CXCL10 MPZ IFNG
5 vision/eye MP:0005391 9.17 MBP AQP4 MOG IFNG PMP22 TNF

Drugs & Therapeutics for Neuritis

Drugs for Neuritis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 797)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 83-43-2 6741
2
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 50-24-8 5755
3
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 53-03-2 5865
4
Glatiramer Acetate Approved, Investigational Phase 4,Phase 3,Phase 2 147245-92-9 3081884
5
Mitoxantrone Approved, Investigational Phase 4 65271-80-9 4212
6
Stavudine Approved, Investigational Phase 4,Phase 3 3056-17-5 18283
7
Fexofenadine Approved, Investigational Phase 4 83799-24-0 3348
8
Gabapentin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 60142-96-3 3446
9
Histamine Approved, Investigational Phase 4,Phase 1,Phase 2,Not Applicable 51-45-6, 75614-87-8 774
10
Pregabalin Approved, Illicit, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 148553-50-8 5486971
11
Imipramine Approved Phase 4 50-49-7 3696
12
Etoricoxib Approved, Investigational Phase 4,Phase 2 202409-33-4 123619
13
Ketamine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 6740-88-1 3821
14
Acetaminophen Approved Phase 4,Phase 3,Phase 2,Not Applicable 103-90-2 1983
15
Morphine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 57-27-2 5288826
16
Capsaicin Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 404-86-4 1548943
17
Bupivacaine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 38396-39-3, 2180-92-9 2474
18
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 50-02-2 5743
19
Epinephrine Approved, Vet_approved Phase 4,Not Applicable 51-43-4 5816
20
Mannitol Approved, Investigational Phase 4,Phase 1,Phase 2 69-65-8 6251 453
21 Racepinephrine Approved Phase 4,Not Applicable 329-65-7
22
Acetylcholine Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 51-84-3 187
23
Hydroxocobalamin Approved Phase 4,Phase 3,Phase 2,Not Applicable 13422-51-0 5460373 44475014 11953898
24
Naloxone Approved, Vet_approved Phase 4,Phase 2 465-65-6 5284596
25
Oxycodone Approved, Illicit, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 76-42-6 5284603
26
Nabilone Approved, Investigational Phase 4,Phase 3,Phase 2 51022-71-0 5284592
27
gamma-Aminobutyric acid Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 56-12-2 119
28
Levobupivacaine Approved, Investigational Phase 4,Phase 3,Not Applicable 27262-47-1 92253
29
Ropivacaine Approved Phase 4,Phase 3,Phase 2,Not Applicable 84057-95-4 175805 71273
30
Lidocaine Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 137-58-6 3676
31
Paclitaxel Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 33069-62-4 36314
32
Dopamine Approved Phase 4,Phase 3,Phase 2,Not Applicable 51-61-6, 62-31-7 681
33
Norepinephrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-41-2 439260
34
Tramadol Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 27203-92-5 33741
35
Amitriptyline Approved Phase 4,Phase 3,Phase 2,Not Applicable 50-48-6 2160
36
Guaifenesin Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 93-14-1 3516
37
Minocycline Approved, Investigational Phase 4,Phase 2,Not Applicable 10118-90-8 5281021
38
Perphenazine Approved Phase 4,Phase 3,Phase 2,Not Applicable 58-39-9 4748
39
Triamcinolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 124-94-7 31307
40
Carbamazepine Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 298-46-4 2554
41
Oxcarbazepine Approved Phase 4,Not Applicable 28721-07-5 34312
42
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1994-09-7, 94-09-7 2337
43
Dronabinol Approved, Illicit Phase 4,Phase 3,Phase 2 1972-08-3 16078 2978
44
Ethanol Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 64-17-5 702
45
Naproxen Approved, Vet_approved Phase 4,Phase 2 22204-53-1 156391 1302
46
Remifentanil Approved Phase 4,Phase 3,Not Applicable 132875-61-7 60815
47
Interferon beta-1a Approved, Investigational Phase 4,Phase 3,Phase 2 145258-61-3 6438354
48
Clofazimine Approved, Investigational Phase 4 2030-63-9 2794
49
Dapsone Approved, Investigational Phase 4 80-08-0 2955
50
Rifampin Approved Phase 4,Not Applicable 13292-46-1 5381226 5458213

Interventional clinical trials:

(show top 50) (show all 2325)

# Name Status NCT ID Phase Drugs
1 A Phase IV Trial of Neuroprotection With ACTH in Acute Optic Neuritis Unknown status NCT01838174 Phase 4 ACTHAR Gel (ACTH);IV steroids with oral taper
2 Optical Coherence Tomography: Glatiramer in Clinically Isolated Syndrome or Early Relapsing Remitting Multiple Sclerosis (MS) Unknown status NCT00910598 Phase 4 glatiramer acetate
3 Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders Unknown status NCT02021825 Phase 4 Mitoxantrone
4 Bi-Axial Rotating Magnetic Field Therapy in Refractory Neuropathic Foot Pain Secondary to Diabetic Peripheral Neuropathy Unknown status NCT00123136 Phase 4
5 Evaluation of Viral Efficacy and Safety of a Reduced Dose of Stavudine (d4T): THE PHOENIX STUDY Unknown status NCT00235222 Phase 4 stavudine
6 Pregabalin for the Treatment of Uremic Pruritus Unknown status NCT01852318 Phase 4 pregabalin 75mg daily for 12 weeks;fexofenadine 60 mg daily for 12 weeks;placebo
7 A Post-marketing Evaluation of a Compound Traditional Chinese Herbal Medicine, Qishe Pill, on Cervical Radiculopathy Unknown status NCT01875562 Phase 4 Qishe Pill
8 Imipramine and Pregabalin Combination in Painful Polyneuropathy Unknown status NCT01047488 Phase 4 Imipramine;Pregabalin;Imipramine, pregabalin;Placebo
9 Evaluation of the Efficacy, Tolerability and Safety of Etoricoxib (Arcoxia) in Patients With Neuropathic Pain Unknown status NCT01264237 Phase 4 Etoricoxib;Placebo
10 Conservative Versus Aggressive Discectomy for Primary Disc Herniation With Radiculopathy Unknown status NCT01204008 Phase 4
11 Muscular Electrostimulation of the Sedated and Mechanically Ventilated Critically Ill Patient. Analysis of the Effect on Acquired Muscular Weakness and Its Clinical Consequences. Unknown status NCT02033057 Phase 4
12 Preventing Pain After Heart Surgery Unknown status NCT01480765 Phase 4 Pregabalin;Ketamine infusion;Placebo capsules;Placebo infusion
13 IV Paracetamol vs IV Morphine vs Placebo in Sciatalgia Unknown status NCT02504996 Phase 4 Paracetamol;morphine;Placebo
14 Qutenza for Critical Ischaemia in End Stage Renal Failure Unknown status NCT01704339 Phase 4 QUTENZA
15 Evaluation of the Impact of Training on Outcome Measures in Subjects With Painful Diabetic Neuropathy Unknown status NCT01770964 Phase 4 Pregabalin;placebo
16 Pregabalin for the Treatment and Prevention of Spinal Cord Injury Neuropathic Pain Unknown status NCT01479556 Phase 4 Pregabalin;Placebo
17 Effects of Pregabalin on Mechanical Hyperalgesia Unknown status NCT00310583 Phase 4 Pregabalin
18 Inspiratory Muscle Training in Patients With Autonomic Neuropathic Unknown status NCT00752440 Phase 4
19 Effect of High-Dose Prednisolone (Solu Dacortin®) Treatment on Choroidal and Optic Nerve Head Blood Flow in Humans Completed NCT00312325 Phase 4 Prednisolone
20 Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis Completed NCT00179478 Phase 4 interferon beta 1a 30 ug IM once weekly
21 Dexamethasone & Bupivacaine vs Bupivacaine Alone in Combined Femoral and Sciatic Nerve Block for Perioperative Analgesia in Patients Undergoing Lower Limb Surgeries Completed NCT02576782 Phase 4 Perineural Dexamethasone and bupivacaine;Systemic Dexamethasone plus perineural bupivacaine;intravenous saline plus perineural bupivacaine
22 Oral Corticotherapy in Megadoses to Treat Multiple Sclerosis During Relapse Completed NCT00753792 Phase 4 methylprednisolone;methylprednisolone;Placebo
23 Postmarketing Safety Study of Q/LAIV in Subjects 2 Through 49 Years of Age Completed NCT01985997 Phase 4
24 Uniform Multidrug Therapy Regimen for Leprosy Patients Completed NCT00669643 Phase 4 PB 6 doses - Rifampicin and Dapsone;PB 6 doses - Rifampicin, Clofazimine and Dapsone;MB 12 doses - Rifampicin, Clofazimine and Dapsone;MB 6 doses - Rifampicin, Clofazimine and Dapsone
25 Evaluation of Ureteral Patency in the Post-indigo Carmine Era Completed NCT02677623 Phase 4 Pyridium;Sodium Fluorescein;Mannitol
26 Study to Evaluate the Efficacy of Botulinum Toxin Serotype A Injections for Cervicobrachial Myofascial Syndrome Completed NCT00241215 Phase 4 Botulinum toxin serotype A
27 A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic’s Disease) Completed NCT00304291 Phase 4 Mitoxantrone
28 Safety and Efficacy of Mecobalamin Injection in Peripheral Neuropathies Patients (Study JGAZSY091109) Completed NCT01192113 Phase 4 Mecobalamin IV Injection;Mecobalamin IM injection;Mecobalamin IV or IM injection
29 A Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN) Completed NCT01675531 Phase 4 Targin
30 Safety of Pregabalin in the Treatment of Pain Due to Diabetic Peripheral Neuropathy Completed NCT00159731 Phase 4 Pregabalin
31 Study of Metanx® in Subjects With Type 2 Diabetic Peripheral Neuropathy (DPN) Completed NCT00726713 Phase 4
32 Efficacy of Administration of ACE-Inhibition on Autonomic and Peripheral Neuropathy in Patients With Diabetes Mellitus Completed NCT03031834 Phase 4 Quinapril
33 Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Diabetic Peripheral Neuropathy Completed NCT00380913 Phase 4 Cesamet™ (nabilone)
34 Pregabalin in the Treatment of Pain Due to Diabetic Peripheral Neuropathy Completed NCT00159679 Phase 4 Pregabalin
35 A Study To Evaluate Pregabalin In Patients With Painful Diabetic Peripheral Neuropathy (DPN) Completed NCT00156078 Phase 4 pregabalin
36 A Study of the Efficacy and Safety of Pregabalin for the Treatment of Diabetic Peripheral Neuropathy or Postherpetic Neuralgia Completed NCT00629681 Phase 4 Pregabalin
37 Efficacy and Safety of Gabapentin/B-complex Versus Pregabalin in Diabetic Peripheral Neuropathy Pain Management Completed NCT01364298 Phase 4 Gabapentin/B-complex;Pregabalin
38 Pregabalin Treatment Of Peripheral Neuropathic Pain Associated With Diabetic Peripheral NeP (DPN), Postherpetic Neuralgia (PHN), HIV-related NeP (HIV), and Chemotherapy Induced NeP Completed NCT00407511 Phase 4 Pregabalin
39 Intrathecal Bolus Doses of Ziconotide Completed NCT01373983 Phase 4 Ziconotide
40 Comparison of the Analgesic Effect of Different Local Anesthetics in Interscalene Nerve Block for Shoulder Surgery Completed NCT02691442 Phase 4 Ropivacaine 0.75%;Levobupivacaine 0.5%;Levobupivacaine 0.5% + epinephrin 1/200000
41 Effect of Pulsing Electrical Fields on Lower Extremity Diabetic Neuropathy: A Pilot, Open-Label Study Completed NCT00614341 Phase 4
42 Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Chemotherapy-Induced Neuropathy Completed NCT00380965 Phase 4 Cesamet™ (nabilone)
43 A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions Completed NCT00904202 Phase 4 Placebo Capsules + Placebo Patch;Placebo capsules + Lidoderm®;Gabapentin + Placebo;Gabapentin + Lidoderm®;Gabapentin 300 mg capsules 1800 mg/day + placebo patch;Gabapentin 1800 mg/day + Lidoderm patch
44 Frequency Modulated Neural Stimulation (FREMS) in Symptomatic Diabetic Neuropathy Completed NCT01628627 Phase 4
45 Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly Completed NCT02151149 Phase 4 nab-paclitaxel;Carboplatin
46 A Randomized Double-Blind Study Testing the Effects of Pregabalin on Diabetic Neuropathy Completed NCT00573261 Phase 4 Pregabalin;Placebo
47 Comparison of the Efficacy of Duloxetine With Placebo in Patients With Chronic Low Back Pain With a Radicular Component Completed NCT01166048 Phase 4 Duloxetine;Duloxetine
48 Effect of Arginine on Microcirculation in Patients With Diabetes Completed NCT00902616 Phase 4
49 An Open Label, Dose Finding Trial of Viagra for the Treatment of Neuropathic Pain (in Diabetes Mellitus) Completed NCT00194909 Phase 4 sildenafil (Viagra)
50 Asian Study on Cilostazol Effectivity in Neuropathies of Diabetes Mellitus Type 2-A Pilot Study in the Philippines Completed NCT01076478 Phase 4 Cilostazol

Search NIH Clinical Center for Neuritis

Cochrane evidence based reviews: neuritis

Genetic Tests for Neuritis

Anatomical Context for Neuritis

MalaCards organs/tissues related to Neuritis:

38
Eye, Brain, T Cells, Testes, Bone, Pituitary, Spinal Cord

Publications for Neuritis

Articles related to Neuritis:

(show top 50) (show all 1120)
# Title Authors Year
1
High resolution retinal scanning reveals regional structural differences between MS and NMOSD optic neuritis regardless of antibody status. ( 29249380 )
2018
2
Clinical features of demyelinating optic neuritis with seropositive myelin oligodendrocyte glycoprotein antibody in Chinese patients. ( 29363529 )
2018
3
Guillain-BarrAc syndrome and optic neuritis after Mycoplasma pneumoniae infection. ( 29429558 )
2018
4
Anatomical Wiring and Functional Networking Changes in the Visual System Following Optic Neuritis. ( 29297053 )
2018
5
Retinal nerve fiber layer and ganglion cell layer changes on optical coherence tomography in early multiple sclerosis and optic neuritis cases. ( 29283135 )
2018
6
Progressive inner nuclear layer dysfunction in non-optic neuritis eyes in MS. ( 29259999 )
2018
7
Erratum: Progressive inner nuclear layer dysfunction in non-optic neuritis eyes in MS. ( 29417957 )
2018
8
Early Nodal and Paranodal Disruption in Autoimmune Optic Neuritis. ( 29444299 )
2018
9
MRI Findings in Varicella Zoster Trigeminal Neuritis Without Rash. ( 29399793 )
2018
10
Advanced diffusion-weighted imaging in patients with optic neuritis deficit - value of reduced field of view DWI and readout-segmented DWI. ( 29417865 )
2018
11
Diagnosis and treatment of anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis. ( 29445944 )
2018
12
Active Leprosy Neuritis Detected on FDG PET/CT. ( 29261639 )
2018
13
Valuable Insights Into Visual Neuroplasticity After Optic Neuritis. ( 29297048 )
2018
14
Paediatric ADEM followed by optic neuritis: disease course, treatment response and outcome. ( 29443442 )
2018
15
Clinical value of 4-hour delayed gadolinium-Enhanced 3D FLAIR MR Images in Acute Vestibular Neuritis. ( 29330961 )
2018
16
Incidence and Causes of Overdiagnosis of Optic Neuritis. ( 29222573 )
2018
17
Anti-NMDA-receptor optic neuritis in a patient with a history of encephalitis. ( 29217046 )
2017
18
Retinal segmented layers with strong aquaporin-4 expression suffered more injuries in neuromyelitis optica spectrum disorders compared with optic neuritis with aquaporin-4 antibody seronegativity detected by optical coherence tomography. ( 28057643 )
2017
19
Postinfectious Anti-Myelin Oligodendrocyte Glycoprotein Antibody Positive Optic Neuritis and Myelitis. ( 28820014 )
2017
20
Time is vision in recurrent optic neuritis. ( 28823952 )
2017
21
Diagnostic accuracy of optical coherence tomography inter-eye percentage difference for optic neuritis in multiple sclerosis. ( 28887838 )
2017
22
The Renin-Angiotensin System Regulates Neurodegeneration in a Mouse Model of Optic Neuritis. ( 28919108 )
2017
23
Concurrent intramedullary spinal cord and multiple intracranial tuberculomas with tuberculous optic neuritis: A rare case report. ( 28941861 )
2017
24
Transorbital Sonography and Visual Outcome for the Diagnosis and Monitoring of Optic Neuritis. ( 27862614 )
2017
25
Typical sensory organization test findings and clinical implication in acute vestibular neuritis. ( 29258799 )
2017
26
Recurrent isolated optic neuritis: A study on 22 patients. ( 29114368 )
2017
27
Therapeutic benefit of environmental enrichment on optic neuritis. ( 29233635 )
2017
28
Infant brachial neuritis following a viral prodrome: a case in a 6-month old child and review of the literature. ( 28884231 )
2017
29
A Functional and Neuropathological Testing Paradigm Reveals New Disability-Based Parameters and Histological Features for P0180-190-Induced Experimental Autoimmune Neuritis in C57BL/6 Mice. ( 28082327 )
2017
30
Paediatric optic neuritis: factors leading to unfavourable outcome and relapses. ( 28903961 )
2017
31
Attenuation of experimental autoimmune neuritis with locally administered lovastatin-encapsulating poly(lactic-co-glycolic) acid nanoparticles. ( 27861905 )
2017
32
Clinical Profile and Outcomes of Optic Neuritis in an HIV Prevalent Urban Community in South Africa. ( 29279653 )
2017
33
Optic neuritis in patients with anti-MOG antibodies spectrum disorder: MRI and clinical features from a large multicentric cohort in France. ( 28914353 )
2017
34
Should Oral Corticosteroids Be Used to Treat Demyelinating Optic Neuritis? ( 28857910 )
2017
35
Prognostic factors and disease course in aquaporin-4 antibody-positive Chinese patients with acute optic neuritis. ( 28879451 )
2017
36
Long-term structural retinal changes in patients with optic neuritis related to multiple sclerosis. ( 28860702 )
2017
37
Optic neuritis in dogs: 96 cases (1983-2016). ( 29251394 )
2017
38
Prevalence and Incidence of Optic Neuritis in Patients with Different Types of Uveitis. ( 28895765 )
2017
39
Pediatric Optic Neuritis. ( 28941527 )
2017
40
Neuroprotection and visual function after optic neuritis. ( 27941524 )
2017
41
Thickness of macular inner retinal layers and peripapillary retinal nerve fibre layer in neuromyelitis optica spectrum optic neuritis and isolated optic neuritis with one episode. ( 27775238 )
2017
42
Cortical blindness and not optic neuritis as a cause of vision loss in a SjAPgren's syndrome (SS) patient with the neuromyelitis optica spectrum disorder (NMOSD): Challenges of ascribing demyelinating syndromes to SS: a case report. ( 28834867 )
2017
43
Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration. ( 27844165 )
2017
44
Optic neuritis in a patient with celiac disease. ( 28803640 )
2017
45
Clinical usefulness of prognostic biomarkers in optic neuritis. ( 29272057 )
2017
46
Isolated optic neuritis associated with Mycoplasma pneumoniae infection: report of two cases and literature review. ( 28321515 )
2017
47
Chronic Brachial Plexus Neuritis that Developed into Typical Neuralgic Amyotrophy and Positively Responded to Immunotherapy. ( 29269655 )
2017
48
A case of MOG antibody-positive bilateral optic neuritis and meningoganglionitis following a genital herpes simplex virus infection. ( 29055448 )
2017
49
Bevacizumab for Radiation Induced Optic Neuritis Among Aggressive Residual/Recurrent Suprasellar Tumors: More Than a Mere Antineoplastic Effect. ( 28754639 )
2017
50
Magnetic resonance imaging findings at the first episode of acute optic neuritis. ( 29291481 )
2017

Variations for Neuritis

Expression for Neuritis

Search GEO for disease gene expression data for Neuritis.

Pathways for Neuritis

Pathways related to Neuritis according to GeneCards Suite gene sharing:

(show all 49)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.3 CCL2 CCL5 CXCL10 IFNG IL1B IL4
2
Show member pathways
13.23 CCL2 CCL5 CXCL10 IL1B IL4 TNF
3
Show member pathways
12.75 CCL2 CCL5 CXCL10 IFNG IL1B IL4
4
Show member pathways
12.68 CCL5 CXCL10 IFNG IL1B TNF
5
Show member pathways
12.54 IFNG IL1B IL4 TNF
6
Show member pathways
12.53 CCL2 IFNG IL1B TNF
7
Show member pathways
12.49 CCL2 CCL5 CXCL10 IFNG IL1B TNF
8
Show member pathways
12.38 IFNG IL1B IL4 TNF
9 12.31 CCL2 CCL5 CXCL10 IFNG IL1B IL4
10
Show member pathways
12.24 CCL2 CCL5 IFNG IL1B IL4 TNF
11
Show member pathways
12.21 IFNG IL1B IL4 TNF
12
Show member pathways
12.21 CCL2 CXCL10 IFNG IL1B IL4 TNF
13
Show member pathways
12.17 CXCL10 IFNG IL1B IL4 TNF
14
Show member pathways
12.12 IFNG IL1B IL4 TNF
15 12.06 CCL2 IFNG IL1B TNF
16 11.99 IFNG IL1B TNF
17 11.96 CCL2 IL1B IL4 TNF
18
Show member pathways
11.94 CCL2 CCL5 CXCL10
19 11.94 IFNG IL4 TNF
20 11.93 CCL2 CCL5 CXCL10 IL1B TNF
21
Show member pathways
11.92 IFNG IL1B IL4
22
Show member pathways
11.88 IFNG IL1B TNF
23 11.87 MBP MPZ PMP22
24 11.85 CCL2 IL1B TNF
25 11.84 IL1B IL4 TNF
26 11.83 IFNG IL1B TNF
27
Show member pathways
11.8 IFNG IL1B IL4
28 11.78 IFNG IL1B IL4 TNF
29
Show member pathways
11.72 IFNG IL4 TNF
30 11.72 CCL2 CCL5 IFNG IL1B TNF
31 11.7 IFNG IL1B TNF
32
Show member pathways
11.63 IFNG IL1B TNF
33 11.54 CCL2 IFNG IL1B TNF
34 11.52 CCL2 IFNG IL1B TNF
35 11.49 IFNG IL1B TNF
36 11.46 IFNG IL1B TNF
37 11.37 CXCL10 IFNG IL1B
38 11.36 AQP4 CCL2 CXCL10 IFNG IL1B IL4
39 11.35 CCL2 CCL5 IL1B IL4 TNF
40 11.33 IFNG IL1B TNF
41 11.28 IFNG IL1B IL4 TNF
42 11.23 IFNG IL1B IL4 TNF
43 11.16 CCL2 IFNG IL1B
44 11.12 CCL2 CCL5 CXCL10 IL1B IL4 TNF
45 11.03 CCL2 CCL5 CXCL10 IL1B IL4 TNF
46 10.97 CCL2 CCL5 CXCL10 IL1B IL4 TNF
47 10.95 CCL2 IL1B TNF
48 10.75 IL1B IL4
49 10.56 MAG MBP

GO Terms for Neuritis

Cellular components related to Neuritis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.7 CCL2 CCL5 CXCL10 IFNG IL1B IL4
2 myelin sheath GO:0043209 9.26 MAG MBP MPZ PMP2
3 compact myelin GO:0043218 8.8 MAG MBP PMP22

Biological processes related to Neuritis according to GeneCards Suite gene sharing:

(show all 33)
# Name GO ID Score Top Affiliating Genes
1 inflammatory response GO:0006954 9.95 CCL2 CCL5 CXCL10 IL1B TNF
2 MAPK cascade GO:0000165 9.85 CCL2 CCL5 IL1B MBP TNF
3 cellular response to lipopolysaccharide GO:0071222 9.83 CCL2 CXCL10 TNF
4 chemotaxis GO:0006935 9.81 CCL2 CCL5 CXCL10 IL4
5 cellular response to interferon-gamma GO:0071346 9.8 AQP4 CCL2 CCL5